drugset / Trial / NCT00748150

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects

NCT00748150 ↗

Phase 2 Completed 143 enrolled Novartis Vaccines
Non-randomizedSingle-groupOpen-labelPrevention

Summary

Annual trial for registration influenza vaccine with the strain composition for season 2008/2009

Timeline

Start
2008-07
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Vaccine (Surface Antigen, Inactivated) Vaccine 0.5 ml —

Indications